nach oben

Indian Journal of Hematology and Blood Transfusion

Erschienen in:

22.09.2020 | Original Article

Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors

verfasst von: Rabab Hasanain Ahmed Hasanain, Rania M. Saleh, Fadia M. Attia, Hanaa H. Gomaa

Erschienen in: Indian Journal of Hematology and Blood Transfusion | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Up till now, screening for human parvovirus B19 is not routine in national Egyptian blood bank strategy. Blood samples were collected from 500 healthy blood donors within the age range from 18 to 45 years old attending the blood bank of Suez Canal University Hospital, Ismailia, Egypt. Sera were separated and stored at − 20 °C. Serum samples were screened for anti-human parvovirus B19 IgM and IgG antibodies and B19 genome using ELISA and real-time PCR respectively. Frequency of B19 IgM and B19 IgG antibodies was 6.20%, and 80.20% respectively, and the prevalence of B19 genome was 3.00%. There is a high frequency of human parvovirus B19 among Egyptian blood donors; therefore, serological screening for B19 is warranted.

Kaufman B, Simpson A, Rossmann M (2004) The structure of human parvovirus B19. P Natl Acad Sci USA 101:11628–11633CrossRef

Cotmore SF, Agbandje-McKenna M, Chiorini JA et al (2014) The family parvoviridae. Arch Virol 2014(159):1239–1247CrossRef

Bönsch C, Kempf C, Ros C (2008) Interaction of parvovirus B19 with human erythrocytes alters virus structure and cell membrane integrity. J Virol 82:11784–11791CrossRef

Sol N, Junter J, Vassias I, Freyssiner J, Thomas A, Prigent A et al (1999) Possible interactions between the NS-1 protein and tumor necrosis factor-alpha pathways in erythroid cell apoptosis induced by human parvovirus B19. J Virol 73:8762–8770CrossRef

Zhi N, Mills I, Lu J, Wong S, Filippone C, Brown K (2006) Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity. J Virol 80:5941–5950CrossRef

Morita E, Tada K, Chisaka H, Asao H, Sato H, Yaegashi N, Sugamura K (2001) Human parvovirus B19 induces cell cycle arrest at G2 phase with accumulation of mitotic cyclins. J Virol 75:7555–7563CrossRef

Mortimer PP, Humphries RK, Moore JG, Purcell RH, Young NS (1983) A human parvovirus-like virus inhibits haematopoietic colony formation in vitro. Nature 302:426–429CrossRef

Weigel-Kelley KA, Yoder MC, Chen L, Srivastava A (2006) Role of integrin cross-regulation in parvovirus B19 targeting. Hum Gene Ther 17:909–920CrossRef

Weigel-Kelley K, Yoder M, Srivastava A (2003) Alpha-5 beta-1 integrin as a cellular co-receptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry. Blood 102:3927–3933CrossRef

10.

Heegaard E, Brown K (2002) Human parvovirus B19. Clin Microbiol Rev 15:485–505CrossRef

11.

Erdman DD, Anderson BC, Torok TJ, Finkel TH, Anderson LJ (1997) Possible transmission of parvovirus B19 from intravenous immune globulin. J Med Virol 53:233–236CrossRef

12.

Miller E, Fairley CK, Cohen BJ, Seng C (1998) Immediate and long-term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 105:174–178CrossRef

13.

Santagostino E, Mannucci PM, Gringeri A, Azzi A, Morfini M, Musso R et al (1997) Transmission of parvovirus B19 by coagulation factor concentrates exposed to 100 degrees C heat after lyophilization. Transfusion 37:517–522CrossRef

14.

Kerr S, O’Keeffe G, Kilty C, Doyle S (1999) Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 57:179–185CrossRef

15.

Kudesia G, Wreighitt T (2005) Parvovirus B19. In: Kudesia G, Wreighitt T (eds) Clinical and diagnostic virology. Cambridge University Press, Cambridge, pp 90–93

16.

Corcoran A, Mahon BP, Doyle S (2004) B cell memory is directed towards conformational epitopes of parvovirus B19 capsid proteins and the VP1-unique region. J Infect Dis 189:1873–1880CrossRef

17.

Michel P, Makela A, Korhonen E, Toivola J, Hedman L, Söderlund-Venermo M et al (2008) Purification and analysis of polyhistidine-tagged human parvovirus B19 VP1 and VP2 expressed in insect cells. J Virol Methods 152:1–5CrossRef

18.

Modrow S, Wenzel J, Schimanski S, Schwarzbeck J, Rothe U, Oldenburg J, Jilg W et al (2010) Prevalence of nucleic acid sequences specific for human parvoviruses, hepatitis A and hepatitis E viruses in coagulation factor concentrates. Vox Sang 100:351–358CrossRef

19.

Brown KE, Young NS (1997) Human parvovirus B19: pathogenesis of disease. In: Anderson LJ, Young NS (eds) Monographs in virology, vol 20. Karger, Basel, pp 105–119

20.

Blümel J, Schmidt I, Effenberger W, Seiz H, Willkomnen H, Brackmann HH et al (2002) Parvovirus B19 transmission by heat-treated clotting factor concentrates. Transfusion 42:1473–1481CrossRef

21.

Wu CG, Mason B, Jong J, Erdman D, McKernan L, Oakley M et al (2005) Parvovirus B19 transmission by a high-purity factor VIII concentrate. Transfusion 45:1003–1010CrossRef

22.

Plentz A, Hahn J, Knoll A, Holler E, Jilg W, Modrow S (2005) Exposure of hematologic patients to Parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 45:1811–1815CrossRef

23.

Kumar S, Gupta RM, Sen S, Sarkar RS, Philip J, Kotwal A et al (2013) Seroprevalence of human parvovirus B19 in healthy blood donors. Med J 69(2013):268–272

24.

Al-Danani D, Abou-Donia H, Saudi M, Al-Shamahy H (2008) Seroprevalence of parvovirus B19 IgG among blood donors in Aden, Yemen and Alexandria, Egypt. J Chin Clin Med 3:173–176

25.

Tsujimura M, Matsushita K, Shiraki H, Sato H, Okochi K, Maeda Y (1995) Human parvovirus B19 infection in blood donors. Vox Sang 69:206–212CrossRef

26.

Wakamatsu C, Takakura F, Kojima E, Kiriyama Y, Goto N, Matsumoto K et al (1999) Screening of blood donors for human parvovirus B19 and characterization of the results. Vox Sang 76:14–21CrossRef

27.

Hsu TC, Chen TY, Lin MC, Tzang BS, Tsay GJ (2005) Human parvovirus B19 infection in patients with chronic hepatitis B or hepatitis C infection. J Gastroenterol Hepatol 20:733–738CrossRef

28.

Khameneh ZR, Sepehrvand N, Sohrabi V, Ghasemzadeh N (2014) The seroprevalence of parvovirus B19 among kidney transplant recipients: a single-center study. Saudi J Kidney Dis Transpl 25(1):16–21CrossRef

29.

Azadmanesh K, Mohraz M, Monireh Kazemimanesh M, Aghakhani A, Foroughi M, Banifazl M et al (2015) Frequency and genotype of human parvovirus B19 among Iranian patients infected with HIV. J Med Virol 87:1124–1129CrossRef

30.

Sharif A, Aghakhani A, Velayati AA, Banifazl M, Sharif MR, Razeghi E et al (2016) Frequency and genotype of human parvovirus B19 among Iranian hemodialysis and peritoneal dialysis patients. Intervirology 59:179–185CrossRef

Titel: Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors
verfasst von: Rabab Hasanain Ahmed Hasanain
Rania M. Saleh
Fadia M. Attia
Hanaa H. Gomaa
Publikationsdatum: 22.09.2020
Verlag: Springer India
Erschienen in: Indian Journal of Hematology and Blood Transfusion / Ausgabe 2/2021
Print ISSN: 0971-4502
Elektronische ISSN: 0974-0449
DOI: https://doi.org/10.1007/s12288-020-01356-y

Neu im Fachgebiet Onkologie

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Screening for Human Parvovirus B19 Infection in Egyptian Family Replacement Blood Donors

Abstract

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2021

Systemic Mastocytosis: Response to the Efficacy of Cladribine(2-CdA) with Current Terminology and Approach

The Outcome of Acute Lymphoblastic Leukemia in 109 Adult Iraqi Patients

Association of Interleukin-1β-31C/T, -511T/C and -3954C/T Single Nucleotide Polymorphism and Their Blood Plasma Level in Acquired Aplastic Anemia

Low Dose Iron Therapy in Children with Iron Deficiency: DNA Damage and Oxidant Stress Markers

Primary Bone Lymphoma: A 13 Year Retrospective Institutional Analysis in the Chemo-Immunotherapy Era

Response to Immunosuppressive Therapy in Acquired Aplastic Anaemia: Experience of a Tertiary Care Centre from Eastern India

Neu im Fachgebiet Onkologie

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Adjuvante Brustkrebstherapie: Doppelt hält besser

Update Onkologie